Medicalgorithmics S.A. — Audit Report / Information 2021

Apr 22, 2022

Appendix to the current report no 21/2022 dated on 20.04.2022.

Before the correction:

The financial data related to the consolidated financial statements of the Issuer's Group as of and for the year ended December 31, 2021:

	Carrying amount (before write off)	Increase in impairment allowance	Recoverable amount of BS/position P&L
Intangible assets	206 091	-155 520	50 571
Non-current assets	233 184	-155 520	77 664
Shareholders' equity	202 914	-155 520	47 393
Sales revenues	120 563	0	120 563
Other operating expenses	7 245	155 520	162 765
EBITDA	6 356	-155 520	-149 165
Net profit	-25 118	-155 520	-180 638

CGU Medi-Lynx	Value (k PLN)
Recoverable amount	54 775
Carrying amount	188 558
Impairment	-133 783

CGU MDG S.A.	Value (k PLN)
Recoverable amount	11 548
Carrying amount	33 285
Impairment	-21 737

The financial data related to the separate financial statements of the Issuer as of and for the year ended December 31, 2021:

	Carrying amount (before write off)	Increase in impairment allowance	Recoverable amount of BS/position P&L
Intangible assets	25 444	-21 737	3 707
Financial assets	75 980	-75 883	97
Shares in subsidiaries	80 549	-79 100	1 450
Non-current assets	184 990	-176 720	8 270
Shareholders' equity	236 367	-180 220	56 147
Trade and other receivables	57 458	-3 500	53 958
Current assets	65 302	-3 500	61 802
Sales revenues	46 192	0	46 192
Other operating expenses	321	25 238	25 558
Finance costs	15 917	154 983	170 900
EBITDA	16 069	-25 238	-9 169
Net profit	7 851	-180 220	-172 369

CGU Medi-Lynx	Value (k PLN)
Recoverable amount	47 865
Carrying amount	206 348
Impairment	-158 483

CGU MDG S.A.	Value (k PLN)
Recoverable amount	11 548
Carrying amount	33 285
Impairment	-21 737

After correction:

Data related to the consolidated financial statements of the Issuer's Group as of and for the year ended December 31, 2021:

(k PLN)	Carrying amount (before write-off)	Increase in impairment allowance	Recoverable amount of BS/position P&L
Intangible assets	206 091	-155 520	50 571
Non-current assets	233 184	-155 520	77 664
Shareholders' equity	202 914	-155 520	47 393
Sales revenues	120 563	0	120 563
Other operating expenses	7 245	155 520	162 765
EBITDA	6 356	-155 520	-149 165
Net profit	-25 118	-155 520	-180 638

	CGU Medi-Lynx	Value (k PLN)
Recoverable amount		54 775
Carrying amount		188 558
Impairment		-133 783

CGU MDG S.A.	Value (k PLN)
Recoverable amount	11 548
Carrying amount	33 285
Impairment	-21 737

The data related to the separate financial statements of the Issuer's Group as of and for the year ended December 31, 2021:

(k PLN)	Carrying amount (before write off)	Increase in impairment allowance	Recoverable amount of BS/position P&L
Intangible assets	25 444	-21 737	3 707
Financial assets	75 980	-75 883	97
Shares in subsidiaries	80 549	-79 100	1 450
Non-current assets	184 990	-176 720	8 270
Shareholders' equity	236 367	-180 220	56 147
Trade and other receivables	57 458	-3 500	53 958
Current assets	65 302	-3 500	61 802

Sales revenues	46 192	0	46 192
Other operating expenses	321	25 238	25 558
Finance costs	15 917	154 983	170 900
EBITDA	16 069	-25 238	-9 169
Net profit	7 851	-180 220	-172 369

CGU Medi-Lynx	Value (k PLN)
Recoverable amount	47 865
Carrying amount	206 348
Impairment	-158 483

CGU MDG S.A.	Value (k PLN)
Recoverable amount	11 548
Carrying amount	33 285
Impairment	-21 737